Benjamin L. Palleiko

Benjamin L. Palleiko appears in our data through filings on KalVista Pharmaceuticals, Inc. shares, published by SEC (Form 4). The record holds 60 filings, for trades running from 18 September 2018 to 17 April 2026.

Every open-market trade on record is a sale: 22 sales worth €3.0M. Other entries cover 4 share grants and 34 option exercises. 2026 to date brings no purchases and 1 sale.

The latest filing, published on 20 April 2026, reports an open-market sale of €164k in KalVista Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.